BARCLAYS PLC: FEZ position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of BARCLAYS PLC on FEZ, newest first. How the timeline and the estimate are built.
BARCLAYS PLC held 50,490 FEZ shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 50,490 sharesChange vs previous 13F -62,671 shares
<0.01% of the 13F portfolio, value $3,467,652.
13F-HR 0000312069-26-000223 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 113,161 sharesChange vs previous 13F +55,436 shares
<0.01% of the 13F portfolio, value $7,025,035.
13F-HR 0000312069-26-000139 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F/A 57,725 sharesChange vs previous 13F +21,814 shares
<0.01% of the 13F portfolio, value $3,585,877.
13F-HR/A 0000312069-26-000090 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F/A 35,911 sharesChange vs previous 13F -13,579 shares
<0.01% of the 13F portfolio, value $1,953,918.
13F-HR/A 0000312069-26-000079 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F/A 49,490 sharesChange vs previous 13F -15,228 shares
<0.01% of the 13F portfolio, value $2,382,944.
13F-HR/A 0000312069-26-000080 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F/A 64,718 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $3,445,586.
13F-HR/A 0000312069-26-000089 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).